TScan Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment in USD from 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
TScan Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2020 to Q1 2025.
  • TScan Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $1.53M, a 117% increase year-over-year.
  • TScan Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $3.83M, a 21.6% increase from 2023.
  • TScan Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $3.15M, a 25.5% decline from 2022.
  • TScan Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $4.23M, a 57.5% decline from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

TScan Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.53M +$827K +117% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $705K -$133K -15.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $838K +$307K +57.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $531K -$2.43M -82.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $2.96M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12

TScan Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.83M +$679K +21.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 $3.15M -$1.08M -25.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 $4.23M -$5.72M -57.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $9.94M +$5.7M +135% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $4.24M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.